Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05016596Not ApplicableCompleted

Postprandial Lipids in IBS and Nutritional Treatment

Role: collaborator

NCT04790422Not ApplicableCompleted

Nutrition to Relieve IBS Symptoms by Targeting the Microbiota

Role: collaborator

NCT04798417Not ApplicableCompleted

Nutrition to Relieve IBS Constipation

Role: collaborator

NCT03720314Completed

Microbiota Profiling in IBS

Role: collaborator

NCT03824821Completed

Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire

Role: collaborator

All 5 trials loaded